Inactive Provider
This provider's NPI has been deactivated on 04/15/2026. The information on this page is historical and may no longer be current.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $115,400 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $72,100 | 34 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $43,300 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $17,620 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($17,620) |
| 2020 | $25,680 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($25,680) |
| 2019 | $25,380 | 12 | Shire North American Group Inc ($25,380) |
| 2018 | $22,440 | 10 | Shire North American Group Inc ($22,440) |
| 2017 | $24,280 | 12 | Shire North American Group Inc ($24,280) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 07/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 06/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 05/11/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 04/12/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| 03/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 02/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 01/12/2021 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 12/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 11/10/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 10/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 09/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 08/11/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 06/24/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 06/08/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 05/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 04/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 03/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 02/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 01/06/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 12/05/2019 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 11/05/2019 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 10/07/2019 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 09/04/2019 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
| 08/07/2019 | Shire North American Group Inc | — | Consulting Fee | Cash or cash equivalent | $2,140.00 | General |
About Dr. Henry Downs, MD
Dr. Henry Downs, MD is a Family Medicine healthcare provider based in Coeur D Alene, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447299888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Downs, MD has received a total of $115,400 in payments from pharmaceutical and medical device companies, with $17,620 received in 2021. These payments were reported across 54 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($115,400).
Practice Information
- Specialty Family Medicine
- Location Coeur D Alene, ID
- Active Since 06/04/2006
- Last Updated 01/11/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447299888
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Coeur D Alene
Crystal Pyrak, Md, MD
Family Medicine — Payments: $45,028
Mr. Douglas Linford, Md, MD
Family Medicine — Payments: $7,746
Dr. Alyssa Shaw, M.d, M.D
Family Medicine — Payments: $5,821
Bryan Davidson, Md, MD
Family Medicine — Payments: $5,489
Kelly Nelson, Do, DO
Family Medicine — Payments: $4,509
Dr. Thomas Neal, Md, MD
Family Medicine — Payments: $4,086